简介:Retinoblastoma(RB)isthemostcommonintraocularcancerofinfancyandchildhood.ThiscancerisinitiatedbymutationonRB1,thetumorsuppressorgenethatisresponsiblefortheregulationofbothcellcycleandgnomestabilityinretinalcells.PatientswithaconstitutionalmutationonRB1canbeinherited.RBoccursapproximately1inevery15000-20000livebirths.Theworldwidemortalityforthiscancerisabout5%-11%.However,thisraterisestoabout40%-70%indevelopingcountriesduetoadelayindiagnosis.Awidevarietyofoptionsareavailableforthetreatment,butoftenacombinationoftherapiesisadoptedtooptimizeindividualizedcare.
简介:BACKGROUND:Strokepresentsasatransientorchronicbraindysfunctionandisassociatedwithhighmorbidityandhighmortality.Thedoctorsandscientistswouldliketoarguehowtoenhancethevalidityoftherehabilitationtreatmentandhowtofurtherimprovetheleveloftreatmentonstroke.OBJECTIVE:TheaimofthisstudywastoquantitativelyanalyzethecurrentworldwideprogressinresearchonstrokerehabilitationtreatmentbasedonWebofSciencedatabaseandClinicalTrial.govinthepast10years.METHODS:WeconductedaquantitativeanalysisofclinicaltrialarticlesregardingstrokerehabilitationpublishedinEnglishfrom2003to2013andindexedintheNationalInstitutesofHealthClinicalTrialsregistryandWebofSciencedatabases.DataweredownloadedonMarch15,2013.RESULTS:(1)From2003to2013,2654clinicaltrialsinvestigatingstrokewereindexedinClinicalTrials.gov.Therewereonly58clinicaltrialsregisteredin2003,andtherewasamarkedincreasefrom2005.Atotalof605clinicaltrialsontherehabilitationofstrokewereconductedinthepast10years.(2)TheanalysisshowedthatmostofthetrialsinthefieldwereregisteredbyNorthAmericaninstitutions.WithrespecttotheAsiancountries,ChinaandTaiwanareaofChinaalsopublishedareasonableproportionofthetrials,butcomparativelyspeaking,thenumberoftrialsisreallyrare.Mostoftheinterventionsweredrugs,followedbythedevices,andbehavioralinterventionswererankedthird.(3)Inthepast10years,therewere4052studiesonstrokeindexedbyWebofSciencedatabase.CONCLUSION:Fromperspectiveofresearchprogress,wefoundthatthenumberofclinicaltrialsandpapersonstrokerehabilitationhasincreasedsignificantlyinthepast10years,betweenthemaremarkablepositivecorrelationexists.
简介:目的将为服的梗塞续发症观察温暖挖出的刺破方法的临床的效果。有在有包括标准的一致的服的梗塞续发症的六十个病人随机被划分成一个治疗组和控制的方法组织,在每个组的30个盒子。控制组被给西方的药的基本治疗。治疗组被增加,针灸治疗在西方的药的治疗之上基于。在由健康的国家研究所的治疗摸规模(NIHSS)前后,病人的神经病学的缺点被估计。结果显著药品率是83.3%,全部的有效的率在治疗组是93.3%,对56.7%和70.0%处于在二个组之间的显著药品率和全部的有效的率与统计差别在控制组织(P<0.05)。在治疗以后,NIHSS分数在两个组减少了(P<0.01或P<0.05),并且差别是统计的在二个组之间重要(P<0.01)。结论温暖挖出的刺破方法比在服的梗塞续发症的治疗的西方的药的单个治疗好。
简介:Thelimestone-gypsumfluegasdesulfurization(FGD)processhasbecomethemostwidespreadprocessintheworldforsulfurremoval.Theswirl-et-absorbingwetlimestone-gypsumsinteringFGDtechnologywasdevelopedforsinteringfluegasdesulfurization,andthisprocessproducesvolumesofwastewaterwithvariouscontaminantsthatrequirestreatmentbeforedisposalorreuse.Inthisstudy,thewastewaterqualityfromthreedifferentsinteringFGDsystemsatBaosteelGroupwasinvestigatedandcomparedwithwastewaterfrompowerplantFGD.AtreatmentprocesswasproposedwhichissuitableforsinteringFGDwastewater.Aftertreatmentwithaneutralization,coagulationandsedimentationprocess,heavymetalsinthesinteringFGDwastewaterwerereducedtoalevelmeetingtherelevantemissionstandards,butthepHandammoniaconcentrationweretoohigh,andafurthertreatmentprocesswasneeded.DuetocertainsimilaritiesandcomplementaritiesbetweensinteringFGDwastewaterandcokingwastewater,itisentirelyfeasibletomixthepretreatedsinteringFGDwastewaterintoabiologicalcokingwastewatertreatmentsystem.ThisstudyindicatesthatitisentirelyfeasibletomixpretreatedsinteringFGDwastewaterintothebiologicaltreatmentsystemsusedforcokingwastewaterfromtheironandsteelindustries.